Jeshica Bulsara

Optimisation of liver homogenate procedure to evaluate liver enzymes and lipid biomarkers in mice

Background: Liver disease accounts for 2 million deaths per year worldwide, due to viral hepatitis and hepatocellular carcinoma. Invasive techniques such as liver biopsy remain the gold standard for diagnosing fatty liver diseases and are supported by established scoring systems...